In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for...

The importance of having access to care options and being able to finance this has been laid bare through the experience of the COVID-19 health emergency. While most countries have public options for long-term care and health care, these are not always comprehensive and may not support the needs...

This report, based on a series of initial interviews, and augmented by an extensive survey to which 25 countries in total responded, describes policies and practices adopted by countries to address a number of challenges that are specific to oncology medicines.